Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180,026 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.
Zhao Q, Wang Z, Huang W, Wang Q, Yu S, Zhou T, Han D, Wu Z, Gong H, Sun H, Zhang J, Wei Y, Li H, Zhang Z, Lin H, Li B. Zhao Q, et al. Among authors: zhang j, zhang z. Oncotarget. 2016 Feb 16;7(7):8422-31. doi: 10.18632/oncotarget.6871. Oncotarget. 2016. PMID: 26761213 Free PMC article. Clinical Trial.
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
Xie J, Cao J, Wang JF, Zhang BH, Zeng XH, Zheng H, Zhang Y, Cai L, Wu YD, Yao Q, Zhao XC, Mao WD, Jiang AM, Chen SS, Yang SE, Wang SS, Wang JH, Pan YY, Ren BY, Chen YJ, Ouyang LZ, Lei KJ, Gao JH, Huang WH, Huang Z, Shou T, He YL, Cheng J, Sun Y, Li WM, Cui SD, Wang X, Rao ZG, Ma H, Liu W, Wu XY, Shen WX, Cao FL, Xiao ZM, Wu B, Tian SY, Meng D, Shen P, Wang BY, Wang Z, Zhang J, Wang L, Hu XC. Xie J, et al. Among authors: zhang bh, zhang j, zhang y. Breast Cancer Res Treat. 2018 Apr;168(2):389-399. doi: 10.1007/s10549-017-4609-6. Epub 2017 Dec 11. Breast Cancer Res Treat. 2018. PMID: 29230663 Clinical Trial.
Development and Validation of a Novel Signature to Predict Overall Survival in "Driver Gene-negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter Study.
Cui Y, Fang W, Li C, Tang K, Zhang J, Lei Y, He W, Peng S, Kuang M, Zhang H, Chen L, Xu D, Tang C, Zhang W, Zhu Y, Jiang W, Jiang N, Sun Y, Chen Y, Wang H, Lai Y, Li S, He Q, Zhou J, Zhang Y, Lin M, Chen H, Zhou C, Wang C, Wang J, Zou X, Wang L, Ke Z. Cui Y, et al. Among authors: zhang w, zhang j, zhang h, zhang y. Clin Cancer Res. 2019 Mar 1;25(5):1546-1556. doi: 10.1158/1078-0432.CCR-18-2545. Epub 2018 Nov 2. Clin Cancer Res. 2019. PMID: 30389658
High dose radiation therapy based on normal tissue constraints with concurrent chemotherapy achieves promising survival of patients with unresectable stage III non-small cell lung cancer.
Zhao Q, Liu M, Wang Z, Huang W, Allen Li X, Zhou T, Zhang J, Zhang Z, Wang Q, Yu S, Han D, Sun H, Li H, Lin H, Li B. Zhao Q, et al. Among authors: zhang j, zhang z. Radiother Oncol. 2020 Apr;145:7-12. doi: 10.1016/j.radonc.2019.11.024. Epub 2019 Dec 21. Radiother Oncol. 2020. PMID: 31869678
180,026 results
You have reached the last available page of results. Please see the User Guide for more information.